Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo

…, SD Carlin, G La Rocca, S Lyashchenko… - Science translational …, 2015 - science.org
Glucose and glutamine are the two principal nutrients that cancer cells use to proliferate and
survive. Many cancers show altered glucose metabolism, which constitutes the basis for in …

Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial

…, JA Carrasquillo, SK Lyashchenko… - The Lancet …, 2018 - thelancet.com
Background Diffuse intrinsic pontine glioma is one of the deadliest central nervous system
tumours of childhood, with a median overall survival of less than 12 months. Convection-…

Metabolic Imaging of the Human Brain with Hyperpolarized 13C Pyruvate Demonstrates 13C Lactate Production in Brain Tumor Patients

…, KL Granlund, R Boltyanskiy, SK Lyashchenko… - Cancer research, 2018 - AACR
Hyperpolarized (HP) MRI using [1-13C] pyruvate is a novel method that can characterize
energy metabolism in the human brain and brain tumors. Here, we present the first dynamically …

First-in-humans imaging with 89Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: preliminary pharmacokinetics, biodistribution, and lesion …

…, M Ziolkowska, S Ruan, SK Lyashchenko… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Immunotherapy is becoming the mainstay for treatment of a variety of malignancies, but only
a subset of patients responds to treatment. Tumor-infiltrating CD8-positive (CD8+) T …

A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer

…, JA O'Donoghue, JC Durack, SK Lyashchenko… - Clinical Cancer …, 2015 - AACR
Purpose: Standard imaging for assessing osseous metastases in advanced prostate cancer
remains focused on altered bone metabolism and is inadequate for diagnostic, prognostic, …

Detection of HER2-positive metastases in patients with HER2-negative primary breast cancer using 89Zr-trastuzumab PET/CT

…, SB Solomon, H Kolb, SK Lyashchenko… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Our objective was to determine whether imaging with a human epidermal growth factor
receptor 2 (HER2)–targeted PET tracer can detect HER2-positive metastases in patients with …

89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer

…, JA O'Donoghue, V Beylergil, S Lyashchenko… - European journal of …, 2014 - Springer
Purpose Given the bone tropism of prostate cancer, conventional imaging modalities poorly
identify or quantify metastatic disease. Zr-huJ591 positron emission tomography (PET) …

First-in-human imaging with 89Zr-Df-IAB2M anti-PSMA minibody in patients with metastatic prostate cancer: pharmacokinetics, biodistribution, dosimetry, and lesion …

…, S Ruan, SK Lyashchenko… - Journal of Nuclear …, 2016 - Soc Nuclear Med
We conducted a phase I dose-escalation study with 89 Zr-desferrioxamine-IAB2M ( 89 Zr-IAB2M),
an anti–prostate-specific membrane antigen minibody, in patients with metastatic …

First-in-human human epidermal growth factor receptor 2–targeted imaging using 89Zr-Pertuzumab PET/CT: dosimetry and clinical application in patients with breast …

GA Ulaner, SK Lyashchenko, C Riedl… - Journal of Nuclear …, 2018 - Soc Nuclear Med
In what we believe to be a first-in-human study, we evaluated the safety and dosimetry of 89
Zr-pertuzumab PET/CT for human epidermal growth factor receptor 2 (HER2)–targeted …

[PDF][PDF] Hyperpolarized MRI of human prostate cancer reveals increased lactate with tumor grade driven by monocarboxylate transporter 1

KL Granlund, SS Tee, HA Vargas, SK Lyashchenko… - Cell Metabolism, 2020 - cell.com
Metabolic imaging using hyperpolarized magnetic resonance can increase the sensitivity of
MRI, though its ability to inform on relevant changes to biochemistry in humans remains …